UC San Diego Partners with Janssen to Research New Approaches to Treat Metabolic Diseases
Health & BehaviorUniversity of California San Diego School of Medicine has entered a five-year strategic partnership with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover meaningful treatments for metabolic diseases.